Can community health workers help close the heart health gap in philadelphia?
NCT ID NCT06732102
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding a structured self-management program (DECIDE) to standard community health worker support helps 500 Philadelphia residents aged 35-75 better manage heart disease risks and meet their social needs. Participants will either receive the enhanced program or continue with usual services. Researchers will measure improvements in self-care skills and resolution of social needs like housing or food access.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- community health worker support and a self-management education program called DECIDE
- What this could lead to
- If it works, this could show that combining self-management training with community health worker help improves heart health and reduces social needs in underserved communities.
- What could go wrong
- This is a behavioral study, not a drug trial, so results depend on participation and may not apply to other cities. It is also early-stage research, so benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
35 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Reside in Philadelphia * Be between 35 and 75 years of age (inclusive) * Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions: 1. Pre-diabetes 2. Diabetes 3. Hypertension 4. Hyperlipidemia/ high cholesterol) 5. BMI \>=30. * Have completed an initial visit with a CEO CHW * Have one or more unmet social needs identified in the CEO Intake Form in the following areas: 1. Housing Stability, 2. Food security, 3. Transportation to medical appointments and/or work, 4. Employment, 5. Household utilities, 6. Healthcare access, 7. Health literacy, and 8. Social support. * Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment. Exclusion Criteria: * Does not reside in Philadelphia * Not between 35 and 75 years of age (inclusive) * Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions: 1. Pre-diabetes 2. Diabetes 3. Hypertension 4. Hyperlipidemia/ high cholesterol) 5. BMI \>=30. * Has not completed an initial visit with a CEO CHW * Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas: 1. Housing Stability, 2. Food security, 3. Transportation to medical appointments and/or work, employment, 4. Household utilities, 5. Healthcare access, 6. Health literacy, and 7. Social support. * Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Can a nurse and a neighbor help tame chronic disease?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can pressing six points on the body help older adults sleep?